Tissue Repair and Regeneration Research
Preclinical investigation of compounds studied for wound healing, angiogenesis, tendon repair, and connective tissue regeneration in rodent injury models.
Research Overview
Tissue repair and regeneration research examines the molecular and cellular mechanisms by which damaged tissues restore structural integrity and function, using animal injury models and in vitro wound assay systems. This domain has produced an extensive preclinical literature across multiple research groups examining BPC-157, TB-500, and GHK-Cu in rodent surgical injury paradigms. Sikiric et al. at the University of Zagreb have published more than 200 peer-reviewed papers over three decades documenting BPC-157 effects in Achilles tendon transection models, segmental bone defect models, gut fistula models, and CNS injury paradigms in Wistar rats. TB-500 (Thymosin Beta-4 active fragment) research by Goldstein and colleagues in corneal wound models, murine full-thickness excisional wound models, and rat cardiac infarction models has documented accelerated wound closure and improved cardiomyocyte survival relative to vehicle-treated controls. KPV tripeptide studies in murine colitis models documented reduced intestinal inflammation and improved mucosal barrier integrity compared to untreated DSS-colitis controls.
Key Research Findings
Findings from preclinical in vitro and in vivo model systems. All summaries reference published research models.
Tendon and Ligament Repair in Rodent Surgical Models
Sikiric et al. documented accelerated Achilles tendon healing and improved collagen fiber organization in BPC-157-treated Wistar rats following surgical transection, with treated animals showing statistically greater tensile strength measurements at 7, 14, and 21 days post-injury compared to vehicle controls. Histological analysis in these studies showed improved collagen Type I fiber alignment and reduced inflammatory cell infiltration in BPC-157-treated tendons relative to controls at matched time points.
Wound Closure and Cellular Migration in Murine Models
TB-500 (Thymosin Beta-4 active fragment) was documented by Sosne et al. in corneal wound models in mice and rats to accelerate epithelial wound closure compared to vehicle-treated controls, with the mechanism attributed to actin sequestration-driven enhancement of cell migration at wound edges. Goldstein laboratory studies in full-thickness excisional wound models in mice further documented reduced time to wound closure and improved histological healing scores in TB-500-treated animals.
Gastrointestinal Repair and Mucosal Protection
Multiple studies from the Sikiric group documented BPC-157 protective effects on gastric mucosal lesion area in aspirin, HCl, and ethanol-induced gastric ulcer models in Wistar rats, with BPC-157-treated animals showing substantially reduced lesion areas compared to vehicle controls at matched dose-response concentrations. Studies in DSS-induced colitis murine models documented reduced colon tissue damage scores, reduced inflammatory cytokine levels, and improved epithelial barrier function in BPC-157-treated versus untreated control mice.
Angiogenesis Promotion in Wound and Tissue Models
BPC-157 was documented to upregulate VEGF expression and promote microvessel formation in Matrigel plug assays in mice and in dermal wound tissue sections from treated Sprague-Dawley rats, with CD31-stained microvessel density measurements showing significantly greater vascularity in treated wound beds compared to vehicle-treated controls at day 7 post-injury. Parallel in vitro tube formation assays in HUVEC cells treated with BPC-157 showed increased tube length and branch point number relative to untreated controls.
Compounds Studied in This Area
Research compounds with documented preclinical activity in this domain.
Broader Research Context
Tissue repair research benefits from well-established preclinical model systems that produce reproducible injury paradigms for systematic compound evaluation. The Sikiric laboratory at Zagreb University has created the most extensive single-group literature on BPC-157 in repair models, with independent replication published by research groups in Croatia, Korea, Japan, and the United States. The diversity of tissue systems studied (tendon, gut, CNS, vascular, corneal) in separate injury paradigms strengthens the compound's multi-tissue repair research profile. TB-500 repair research has been advanced primarily by the Goldstein laboratory and collaborators, with the cardiac repair literature providing an additional model system beyond the wound closure paradigms.
Research Questions
Continue Your Research
Browse all research areas or explore the full Research Library for compound comparisons, study indexes, and use case guides.